Sort   by:  
 Page size 
UnknownPatients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.
Not available
S-EPMC5015426 | biostudies-literature
UnknownCerebrospinal Fluid in a Small Cohort of Patients with Multiple Sclerosis Was Generally Free of Microbial DNA.
Not available
S-EPMC5216046 | biostudies-literature
UnknownPhase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
Not available
S-EPMC4021043 | biostudies-literature
TranscriptomicsA Genomic Score Prognostic of Outcome in Trauma Patients
Physiological, anatomical, and clinical laboratory analytic scoring systems (APACHE, Injury Severity Score (ISS)) have been utilized, with limited success, to predict outcome following injury. We hypothesized that a peripheral blood leukocyte gene expression score could predict outcome, including mu...
ORGANISM(S): Homo sapiens 
2009-04-12 | E-GEOD-11375 | biostudies-arrayexpress
UnknownRapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons.
Not available
S-EPMC8983481 | biostudies-literature
TranscriptomicsPatients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial
The AVAglio and RTOG-0825 randomized, placebo-controlled phase III trials in newly diagnosed glioblastoma reported prolonged progression-free survival (PFS), but not overall survival (OS), with the addition of bevacizumab to radiotherapy/temozolomide. To establish whether certain patient subgroups d...
ORGANISM(S): Homo sapiens 
2016-07-06 | E-GEOD-84010 | biostudies-arrayexpress
UnknownGeospatial distribution of Mycobacterium tuberculosis genotypes in Africa.
Not available
S-EPMC6070189 | biostudies-literature
UnknownRisk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study.
Not available
S-EPMC7155017 | biostudies-literature
UnknownFirst-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer.
Not available
S-EPMC9414273 | biostudies-literature
UnknownIndividual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohort.
Not available
S-EPMC8567631 | biostudies-literature
Sort   by:  
 Page size